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 ABSTRACT: Hepatitis B virus (HBV) is one of the major global public health problems, with its attendant risks 
especially among the young adults. Worldwide an estimated two billion people are infected with Hepatitis B 
virus out of which more than 350 million ends up with chronic infection; life style among young adults further 
predisposes them to infection. As a result the prevalence of HBV infection was carried out among adolescents 
using four secondary schools in a Community. Two hundred (200) sera samples were screened using the 
standard ELISA Techniques. Overall result showed that 59 (30%) were Seropositive for the HBsAg. Gender 
distribution showed that male volunteers recorded 27(13.5%)positivity compared to 32(16%) in female subjects. 
Considering age group, male subjects aged 15-17years recorded 8% Seropositivity compared to Females with 
11%. Considering risks factors, based on lifestyle subjects with history of sharing sharp instruments recorded a 
prevalence of 5% compared to those with history of cuts from shared razor blade with 23% Seropositivity, lack 
of awareness among the subjects studied recorded 21%.The Alaninaminotransferase (ALT) result obtained 
showed that 4 (6.8%) of positive subjects had elevated ALT. This study therefore emphasizes the public health 
importance of HBV  in the Community and suggests a prompt public awareness among the youths in these 
localities, while a well designed vaccination schedule is promptly advocated. 
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1. INTRODUCTION  
Hepatitis B virus (HBV) infection represents a 
major health problem, with 2 billion people infected 
worldwide and more than 400 million chronic 
carriers of HBV. Globally it causes about 1.2 
million deaths per year due to various complications 
including chronic hepatitis, cirrhosis, and liver 
cancer, (Hou,2005, Lavanchy 2004) The 
transmission of this disease is believed to be mainly 
by sexual, vertical and intrafamilial routes Bélec et 
al,1988. Previous study on young sexually active 
adults, examined in a Public health clinic for 
sexually transmitted disease in Central African 
Republic, has shown a high prevalence of HBsAg 
(14%) with a prevalence of anti-HBc antibodies at 
89%, Pawlotsky et al, 1995. Prevalence is low in 
persons younger than 12 years, but it increases in 
those older than 12 years (Goldstein et al., 2002) 
Hepatitis B virus (HBV) is a common cause of liver 
disease throughout the world. An estimated one 
third of the world's population has serologic 
evidence of past infection, and the virus causes 
more than 1 million deaths annually..HBV accounts 
for 5-10% of cases of chronic end-stage liver 
disease and 10-15% of cases of Hepatocellular 
carcinoma. 
 Hepatitis B is much more prevalent in other 
areas of the world such as part of Asia including 
Southeast Asia, sub-Saharan Africa and some of the 
Mediterranean countries (Coleman et al., 2005). In 
surveillance study of adolescent life behavior, 
(Kann et al., 2000) reported  on HBV among youths 
where it was observed that most of them are 
involved in alcoholic consumption as a possible risk 
factors for infection with the HBV.. The economic 
burden of HBV infection is substantial because of 
high morbidity and mortality associated with end-
stage liver disease, cirrhosis, and hepatocellular 
carcinoma (HCC) Michielsen, 2005.Hepatitis B 
virus gains entrance into the body through a break 
or mucous membrane or by injection into the blood. 
The virus is transported to the hepatocytes where the 
core protein alone enters the cell nucleus initiating 
self multiplication of the viral genome. The most 
remarkable epidemiological features of HBV 
infection in man is the incubation period which 
extends from 2 to 6 months before the development 
of clinical disease. Identified risks, factors for HBV 
infection include intravenous (IV) drug use, 
exposure to infected blood products and intranasal 
drug use (Alter et al., 1999).High risk factors 
includes sexual activity, multiple sexual partners, 
history of sexually transmitted disease (STD), tattoo 
and skin piercing have also been suggested to be 
associated with increased risk for HBV, (Alter et al., 
1999).  
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In low-endemicity areas, most HBV infections 
occur in adolescents and young adults, and the 
majority of infections are acquired sexually or 
through percutaneous exposure. In high-endemicity 
areas of Africa and Asia, most HBV infections 
occur in the first 5 years of life. Perinatal 
transmission predominates in East and Southeast 
Asia; in Africa, most HBV transmission occurs 
before the age of 5 years, through close contact 
within households, medical procedures, traditional 
scarification, and, possibly, additional unidentified 
mechanisms Merican,et al 2000; Vardas et al,1999. 
The vertical transmission rate may be lower in 
Africa than in Asia partly because of a lower 
prevalence of hepatitis B e antigen (HBeAg) in 
Africa, a major determinant of perinatal 
transmission Roingeard,et al 1993.  
2. Materials and method 
Study area: This study was a community 
impact assessment  research, hence the use  of 
selected Secondary Schools in Mangu Community,  
Mangu Local Government Area Plateau State 
namely:  Mwansat, COCIN, Mangu and Hauwa 
Memorial secondary schools. Mangu community 
where these study locations are situated is is about 
80 kilometers away from the state capital. 
Subject: Two hundred (200) blood samples 
were collected from volunteer subjects within the 
schools, aged between 12-30 years of age, involving 
both sexes. Well detailed and structured 
questionnaires were used to obtain demographic and 
other relevant data from the subjects. 
Ethical clearance /consent: Ethical clearance 
was sought and granted after fulfilling all the ethical 
requirements for using humans as study subjects 
while Informed consent was obtained as a response 
to the consent form issued to each subject recruited 
for the study.  
Collection of samples: About 3-5ml of blood 
was collected by venous puncture from each subject 
via the anticubitel vein after sterilization with 70% 
alcohol soaked in absorbent cotton wool. The sera 
samples obtained were dispensed into a 5ml 
cryovial and stored at -20Oc prior use. 
Processing of sample: The sera samples 
obtained from subjects were dispensed into 
prelabelled cryovials aseptically. The samples were 
transported to Virology laboratory (FCVMLT), 
VOM and stored at- 200c prior use. 
Detection of HBsAg: HBsAg Monolisa 
(ELISA) “HBsAg ULTRA assay is one step enzyme 
immune assay based on the principle of the 
“Sandwich’’ type using monoclonal antibodies 
selected for their ability to bind themselves to the 
various subtypes of HBsAg now recognized by the 
WHO and the most part of variant HBV strains. 
Principle: The monolisa HBsAg ULTRA 
solid phase is coated with monoclonal 
antibodies.The“HBsAg ULTRA conjugate are based 
on the use of monoclonal antibodies from mouse 
and polyclonal antibody from goat against the 
HBsAg. These antibodies are bound to the 
peroxidase Samples with ratio values equal to or 
greater than 1 are considered to be initially positive 
by the monolisa HBsAg ULTRA,which should be 
retested in duplicate before final interpretation.If 
after retesting of a sample, the ratio values of the 2 
duplicates are less  than 1, the initial result is non 
repeatable and the sample is declared to be negative 
with the monolisa “HBsAg ULTRA. 
3. RESULTS:  
Out of the 200 samples from (n-200) students 
aged 15-25 years screened for HBsAg status, 59 
subjects were positive giving a prevalence of 30%. 
The result in table I from cross tabulation showed 
that 27(13.5%) and 32(16%) females tested positive 
out of 86 males and 114 females screened 
respectively. 
Table II is a representation of the age groups 
in relation to the number of positive subjects 
screened for HBsAg of the total number of students 
screened. Prevalence rates of 19% and 9% were 
observed within the age groups 15-17 and 18-
20years of age respectively. Among the different 
age groups screened, subjects aged 15-17 recorded a 
higher prevalence of 19% while those aged 18-20 
showed 9% seropositivity. 
TableIII showed risk factors assessment based 
on clinical history among positive male and female 
subjects to HBsAg. These include history of 
vaccination showing (males 1% females 0.5% 
positivity), family history of HBV infection among 
males recorded 0%,and females 1%, history of 
sexually transmitted diseases showed that (males 
had 0.5% compared to  females 1%), history of 
surgery recorded 0.5% among male subjects, 
compared to females with 0%) history liver disease 
showed that  (males had 0.5% positive response 
with females 0%) and those who had the knowledge 
of HBV infection (males 3% females 3% 
respectively. This showed no significant difference 
among the different subjects in the risk behaviors 
with respect to male and female status.  
Table IV : showed risk factors based on life 
style among positive subjects to HBsAg such as 
sharing of manicure/pedicure instruments, multiple 
sex partners, alcoholics those with accidental cuts 
and those who share blades such as razors and 
clippers with prevalence of 9% and 12.5% among 
males and females. 
Table V: shows the result of serum 
Alaninaminotransferase level (ALT) on positive 
subjects out of 59(100%), showed that 55 (93.2%) 
had normal ALT level and 4 (7%) had evelated ALT 
level.  
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Table I: Prevalence based on sex distribution of HBsAg among the subjects screened.  
Sex No of positive No of negative subjects Total % 
Male 27(13.5%) 59(30%) 86(43%) 
Female 32(16%) 82(41) 114(71%) 
Total 59 (30%) 141(71%) 200(100%) 
 
Table II: Distribution based on age group among subjects screened. 
Age group No of positive subjects No of negative subjects 
15-17 38(19%) 105(52.5%) 
18-20 17(9%) 34(17%) 
21-23 0(0.%) 1(0.5%) 
24-25 1(0.5%) 1(0.5%) 
Total 59(29.5%) 141(29.5%) 
 
Table III: Risk factors based on clinical history amongst subjects screened. 
Risk factors No. of samples No. Positive (%) No. Negative % 
 Males Females Males  Females Males Females 
History 
vaccination 
7 5 2(1%) 1(0.5%) 5(2.5%) 4(2%) 
Family history of 
HBV infection 
3 6 0(0%) 2(1%) 3(1.5%) 4(2%) 
History of 
sexually 
transmitted 
diseases  
3 8 1(0.5%) 2(1%) 2(1%) 6(3%) 
History of surgery  1 4 1(0.5%) 2(1%) 0(0%) 2(1%) 
History of blood 
transfusion 
2 4 0(0%) 2(1%) 2(1%) 2(1%) 
History of those 
diagnosed with 
liver disease 
1 1 1(0.5) 0(0%) 0(0%) 1(0.5%) 
Those who had 
the knowledge of 
HBV infection 
13 20 6(3%) 6(3%) 7(3.5%) 14(14%) 
TOTAL 30 48 11(5.5% 15(6.5%) 19/9.5%) 33(16.5%) 
 
Table IV:   Risk factors based on life style among subjects screened. 
Risk factors No. of samples N0. Positive (%) N0. Negative % 
 Males Females Males  Females Males Females 
Those with 
history of sharing 
pedicures/ 
Medicures 
13 29 3(1.5%) 7(3.5%) 10(5%) 22(6%) 
Those with 
multiple sex 
partners 
1 3 0(0%) 2(1%) 1(0.5%) 1(0.5%) 
Those with 
history of 
alcoholism  
6 2 1(0.5%0) 0(0%) 5(2.5%) 2(1%) 
Those with 
previous history 
of cuts with sharp 
objects 
15 16 4(2%) 3(1.5%) 11(5.5%) 13(6.5%) 
Those who share 
objects such as  
razor blades and 
clippers 
28 44 10(5%) 13(6.5%) 18(7.5%) 31(15.5%) 
Total 63 94 18(9%) 25(12.5%) 45(21%) 69(29.5%) 
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Table V:  Determination of serum Alaninaminotransferase level (ALT) on HBsAg positive subjects 
Age group Sex Total no of positive 
subjects 
ALT Normal ALT 
Abnormal 
15-17 M 16(8%) 15(25.4) 1(1.7) 
 F 22(11%) 19(32.2) 2(3.4) 
18-20 M 10(5%) 10(17) 1(1.7) 
 F 7(3.5%) 7(12.6) 0.(0.0) 
21-23 M 0(0.5%) 0(0.0) 0(0.0) 
 F 1(0.5%) 1(1.7) 0(0.0) 
24-25 M 1(0.5%) 1(1.7) 0.(0.0) 
 F 2(1%) 2(3.4) 0(0.0) 
TOTAL  59(100) 55(93.2) 4(6.8) 
 
 
4. Discussion: 
         Worldwide an estimated two billion people 
have been infected with Hepatitis B virus (HBV) 
and more than 350million have chronic (long-time) 
liver infection (WHO 2011).There are little 
consistent information on  the risk behavior  and 
risk factors on HBV among youths in Nigeria 
(Coleman et al., 2005). It is believed that 25% of 
young children are infected at 1-5 years of age and 
about 1-5% of persons infected as older children 
(Lachaux 1995) and they end up as carriers. The 
danger is that these carriers, though asymptomatic 
might serve as reservoir of the virus and a medium 
for spreading infection among other children. 
 The role of age in contracting hepatitis B 
virus infection has been stressed by Jun, et al., 
(2001). Age at infection is also one of the most 
important factor in-influencing the probability of 
developing chronic HBV infection. The risk of 
subsequent chronic HBV infection is about 90% for 
infants, 25% to 50% for children aged one to five 
years, 5% to 10% for adolescents and 1% to 5% for 
adults. This corelates with the result obtained in this 
study with subjects aged 15-18 and 18-20 years 
recording prevalence of 19% and 9% respectively. 
In the United Nations majority of acute HBV 
infection occur in teenagers and young adults. Half 
of these youths never develop symptoms. In a 
similar study conducted by Ndako et al ,2011 it was 
found that subjects aged 15-19 a recorded 
Prevalence of 18.1% a within the age group 
where the highest number of positivity occurred.  
       Similarly,when gender was considered,males 
recorded 13.5% seropositivity compared to females 
with 16% which is at variance with the result 
obtained by Ndako,et al 2011 in a study conducted 
amond students where males had a prevalence of 
25.5% compared to females with 10.9%. An 
interesting observation in this study (Table 1) was 
that more females (16.0%) were infected with HBV 
than males (13.5%) was no obvious explanation for 
the difference in gender as a risk factor for these 
viral infections, similarly Bwogi et al. (2009) 
reported a lower prevalence of HBV in men than in 
female and suggested the interplay of circumcision 
as protective. This was not the case in this study 
even though it was in an area that male circumcision 
is mandatory. However, the male volunteers were 
very few. This observation is a basis for further 
studies. 
 Considering possible risk factors among 
the youths screened based on their life styles result 
obtained showed that HBV is transmitted through 
several routes (Shulman, 1997: Roy et al., 1999) 
sharing of manicure /pedicure instruments, exposure 
to contaminated blood or bodily fluids, heterosexual 
activity and others this study showed that males had 
1.5% while females had 3.5% also those who had 
multiple sex partners had 0% positivity for males 
and 1% for females. 
 This study correlates with studies from 
mexico where it was showed that early age of sexual 
activity increases the risk of HBV infection 
(Vazquez-Martinez et al., 2003). Alcohol 
consumption recorded 0.5% for males and 0% for 
females this shows that alcohol consumption may 
not be one of the leading causes of Hepatitis 
infection in this study area. Other risk behaviours 
observed among these subjects include sharing of 
sharps such as razor blades, clippers for shaving 
which had the following positivity among males 2% 
and females 1.5%. In this present study, sharing of 
sharp objects, blood transfusion and sexual 
exposure were possible predisposing factors 
observed in the population investigated. Roy et 
al. (1999) found that HBV is transmitted in 
young adults and adolescents mainly through 
unprotected sexual intercourse. 
 In comparing risk behaviors based on 
clinical history among males and females, no 
significant difference, among the two groups was 
recorded. This correlates with a similar work carried 
out among students in Jagindi Tasha Jema’a Local 
government Area Kaduna State by Ndako et al, 
2011. 
 The high prevalence observed may be due 
to contact through other risk factors. This study 
generally has given an over view of HBV activity in 
my location of study.However, acute HBV infection 
occur in individuals with no identifiable risk factors 
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in which the mode of transmission is unknown 
among one third of new cases reported (Hollinger, 
1996), which is similar to my observation in this 
work. According to a report by (Syed), HBV 
prevalence among those involved in transfusion was 
10% of the population screened, which is attributed 
to transfusion from earlier infected subjects (Syed; 
1998). 
 Liver enzyme analysis on HBsAg 
seropositive subjects 59 (100%), showed that 55 
(93.2%) had normal; ALT level and 4(7%) had 
elevated ALT levels. This indicates the risk of 
HBV-related liver disease such as hepatocellular 
carcinoma or eventual liver cancer if no prompt 
attention is sought by these positive subjects. in the 
nearest future as elevated ALT levels are believed to 
be caused by a sudden increase in immune mediated 
lysis of infected hepatocytes (Vandamme and Van, 
2007).World health organization (WHO 2008) 
stated that about 25% of adults who become 
chronically infected during child hood die from 
HBV-related liver cancer or cirrhosis.This may 
suggest the beginning of the disease from the stage 
of active liver disease (Immune clearance), to 
 the stage of non replication as the infected 
subjects get older, in agreement with the work of 
Ogbu and Uneke (2009) which states that in the 
stage of non-replication the third stage of the 
disease, ALT levels are within the reference range 
and HBsAg is still actively replicating. 
 
Conclusion 
 In this study, it was discovered that most of 
the subjects screened had no knowledge of 
 hepatitis B virus (HBV). Since the subjects 
in this area live a communal life of sharing things in 
common, the prevalence recorded is alarming 
considering the mode of lifestyle and predisposing 
risks outlined which calls for  enlightenement on the 
various risk factors that can predispose these youths  
to HBV infections also of equal importance is the 
need for routine screening and management of 
infected individuals which would l help reduce the 
cycle of transmission.Finally,mass immunization of 
children and adolescents against HBV should be 
embarked upon by the Nigerian Government and 
Non-governmental organizations (NGOs). 
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